The Patent Finder

Niiki Pharma Inc.

Also on record
Records under this name other than patents Niiki Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Niiki Pharma Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,362,266Method of manufacturing a ruthenium complex
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,089,578Method of treating neuroendocrine tumors
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,283,208Medicaments and methods for treating cancer
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,135,212Method for treating osteoporosis, osteopenia or low bone mineral density
Formerly held
Lapsed on the fee record
Ended Oct 5, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 5, 2025USPTO record
US 9,725,471Method to prevent cancer metastasis to bone
Formerly held
Lapsed on the fee record
Ended Aug 8, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 8, 2025USPTO record
US 10,463,657Method for treating osteoporosis, osteopenia or low bone mineral density
Formerly held
Lapsed on the fee record
Ended Nov 5, 2023 · USPTO record
Lapsed on the fee recordEnded Nov 5, 2023USPTO record
US 7,919,486Use of gallium(III) complexes for the treatment of melanomas
Formerly held
Lapsed on the fee record
Ended Apr 5, 2023 · USPTO record
Lapsed on the fee recordEnded Apr 5, 2023USPTO record
US 7,338,946Compositions containing a ruthenium(III) complex and a heterocycle
Formerly held
Term ended
Term ended Dec 16, 2022 · USPTO record
Term endedTerm ended Dec 16, 2022USPTO record
US 7,485,659Anticancer compositions, and methods of making and using the same
Formerly held
Term ended
Term ended Jan 28, 2022 · USPTO record
Term endedTerm ended Jan 28, 2022USPTO record
US 7,589,084Anticancer compositions, and methods of making and using the same
Formerly held
Term ended
Term ended Jan 28, 2022 · USPTO record
Term endedTerm ended Jan 28, 2022USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited